Literature DB >> 7138768

Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.

S Swinburne, M Moore, P Cole.   

Abstract

Human bronchoalveolar macrophages were separated from other free lung cells by density sedimentation on Percoll gradients. They were then tested for cytotoxicity against the human lung adenocarcinoma cell line A549, using a Selenomethionine-75 post-labelling assay. The cytotoxicity of the macrophages increased as the effector:target cell ratio was increased, approaching 100% at 20:1. There was no significant difference in the cytotoxicity of macrophages isolated from the lungs of bronchial-carcinoma or non-carcinoma patients. The highly cytotoxic nature of the macrophages was not due to selection of a more potent cytotoxic subpopulation of macrophages on the Percoll gradient, nor to a generally elevated activation of the macrophages due to the pathological conditions in the patients' lungs. An attempt to determine whether low concentrations of macrophages could potentiate target-cell growth proved negative. Cytotoxicity of macrophages for cultured lung target cells was not restricted to A549 cells and is not in accordance with the view that defective bronchoalveolar macrophage cytotoxicity contributes to the emergence of bronchial neoplasia.

Entities:  

Mesh:

Year:  1982        PMID: 7138768      PMCID: PMC2011179          DOI: 10.1038/bjc.1982.247

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Major changes in lymphocyte proliferation evoked by activated macrophages.

Authors:  R Keller
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking.

Authors:  G A Warr; R R Martin
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

4.  Pinocytosis by human alveolar macrophages. Comparison of smokers and nonsmokers.

Authors:  H Yeager; S M Zimmet; S L Schwartz
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

5.  Low yield of pulmonary surfactant in cigarette smokers.

Authors:  T N Finley; A J Ladman
Journal:  N Engl J Med       Date:  1972-02-03       Impact factor: 91.245

Review 6.  Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.

Authors:  K C Lee; D Berry
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

7.  A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro.

Authors:  S J Leibovich; R Ross
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

8.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

9.  Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers.

Authors:  J O Harris; E W Swenson; J E Johnson
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

10.  Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages.

Authors:  C F Nathan; W D Terry
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  4 in total

Review 1.  The alveolar macrophage.

Authors:  R M du Bois
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

2.  Phagocytic activity of alveolar macrophages in patients with bronchogenic carcinoma.

Authors:  J D Gangemi; G N Olsen; C Fechter; J A Hightower; C T Bauguess; L Krech
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Production of tumor necrosis factor-alpha by alveolar macrophages of lung cancer patients.

Authors:  A Okubo; S Sone; S M Singh; T Ogura
Journal:  Jpn J Cancer Res       Date:  1990-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.